Vir Biotechnology (VIR) Net Margin (2018 - 2026)
Vir Biotechnology (VIR) reported Net Margin of 33.51% for Q2 2026, up 9173.38 percentage points from -9139.87% a year earlier and up 433464.55 percentage points from the prior quarter.
Vir Biotechnology (VIR) Net Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vir Biotechnology's Net Margin came in at -82.98%, up 2812.96 percentage points year-over-year; for FY2025, it came in at -638.87%, up 64.53 percentage points from FY2024.
- Net Margin has a five-year change of -247.79 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at -703.40% in FY2024 (+10.29 pp), -713.69% in FY2023 (-745.62 pp), 31.92% in FY2022 (-16.33 pp) and 48.25% in FY2021 (+439.34 pp).
- The Q2 2026 figure ranks as the highest quarterly Net Margin since Q3 2022.
- Year over year, Net Margin gained in two of the last eight quarters, with an average year-over-year change of -61242.62 percentage points.
- The high point for year-over-year Net Margin in five years was Q2 2026 (a gain of 9173.38 percentage points); the low point was Q1 2026 (a drop of 429441.42 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -433431.03% (Q1 2026), -66.99% (Q4 2025) and -67975.42% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Vir Biotechnology | 1.78 Bn | 1.78 Bn | 238.95 Mn | 33.51% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.51% |
| Mar 31, 2026 | -433,431.03% |
| Dec 31, 2025 | -66.99% |
| Sep 30, 2025 | -67,975.42% |
| Jun 30, 2025 | -9,139.87% |
| Mar 31, 2025 | -3,989.61% |
| Dec 31, 2024 | -845.23% |
| Sep 30, 2024 | -8,979.71% |
| Jun 30, 2024 | -4,500.10% |
| Mar 31, 2024 | -115.79% |
| Dec 31, 2023 | -690.85% |
| Sep 30, 2023 | -6,192.23% |
| Jun 30, 2023 | -5,129.71% |
| Mar 31, 2023 | -223.80% |
| Dec 31, 2022 | -205.63% |
| Sep 30, 2022 | 46.81% |
| Jun 30, 2022 | -188.27% |
| Mar 31, 2022 | 42.08% |
| Dec 31, 2021 | 64.63% |
| Sep 30, 2021 | 106.57% |
Vir Biotechnology Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();